Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. 2012

Philipp A Lang, and Karl S Lang, and Haifeng C Xu, and Melanie Grusdat, and Ian A Parish, and Mike Recher, and Alisha R Elford, and Salim Dhanji, and Namir Shaabani, and Charles W Tran, and Dilan Dissanayake, and Ramtin Rahbar, and Magar Ghazarian, and Anne Brüstle, and Jason Fine, and Peter Chen, and Casey T Weaver, and Christoph Klose, and Andreas Diefenbach, and Dieter Häussinger, and James R Carlyle, and Susan M Kaech, and Tak W Mak, and Pamela S Ohashi
Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada M5G 2C1.

Infections with HIV, hepatitis B virus, and hepatitis C virus can turn into chronic infections, which currently affect more than 500 million patients worldwide. It is generally thought that virus-mediated T-cell exhaustion limits T-cell function, thus promoting chronic disease. Here we demonstrate that natural killer (NK) cells have a negative impact on the development of T-cell immunity by using the murine lymphocytic choriomeningitis virus. NK cell-deficient (Nfil3(-/-), E4BP4(-/-)) mice exhibited a higher virus-specific T-cell response. In addition, NK cell depletion caused enhanced T-cell immunity in WT mice, which led to rapid virus control and prevented chronic infection in lymphocytic choriomeningitis virus clone 13- and reduced viral load in DOCILE-infected animals. Further experiments showed that NKG2D triggered regulatory NK cell functions, which were mediated by perforin, and limited T-cell responses. Therefore, we identified an important role of regulatory NK cells in limiting T-cell immunity during virus infection.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008217 Lymphocytic choriomeningitis virus The type species of ARENAVIRUS, part of the Old World Arenaviruses (ARENAVIRUSES, OLD WORLD), producing a silent infection in house and laboratory mice. In humans, infection with LCMV can be inapparent, or can present with an influenza-like illness, a benign aseptic meningitis, or a severe meningoencephalomyelitis. The virus can also infect monkeys, dogs, field mice, guinea pigs, and hamsters, the latter an epidemiologically important host. LCM Viruses,LCMV,LCM Virus,Lymphocytic choriomeningitis viruses
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003141 Communicable Diseases An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host. Infectious Diseases,Communicable Disease,Disease, Communicable,Disease, Infectious,Diseases, Communicable,Diseases, Infectious,Infectious Disease
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006652 Histological Techniques Methods of preparing tissue for examination and study of the origin, structure, function, or pathology. Histologic Technic,Histologic Technics,Histologic Technique,Histologic Techniques,Histological Technics,Technic, Histologic,Technics, Histologic,Technique, Histologic,Techniques, Histologic,Histological Technic,Histological Technique,Technic, Histological,Technics, Histological,Technique, Histological,Techniques, Histological

Related Publications

Philipp A Lang, and Karl S Lang, and Haifeng C Xu, and Melanie Grusdat, and Ian A Parish, and Mike Recher, and Alisha R Elford, and Salim Dhanji, and Namir Shaabani, and Charles W Tran, and Dilan Dissanayake, and Ramtin Rahbar, and Magar Ghazarian, and Anne Brüstle, and Jason Fine, and Peter Chen, and Casey T Weaver, and Christoph Klose, and Andreas Diefenbach, and Dieter Häussinger, and James R Carlyle, and Susan M Kaech, and Tak W Mak, and Pamela S Ohashi
December 2005, Infection and immunity,
Philipp A Lang, and Karl S Lang, and Haifeng C Xu, and Melanie Grusdat, and Ian A Parish, and Mike Recher, and Alisha R Elford, and Salim Dhanji, and Namir Shaabani, and Charles W Tran, and Dilan Dissanayake, and Ramtin Rahbar, and Magar Ghazarian, and Anne Brüstle, and Jason Fine, and Peter Chen, and Casey T Weaver, and Christoph Klose, and Andreas Diefenbach, and Dieter Häussinger, and James R Carlyle, and Susan M Kaech, and Tak W Mak, and Pamela S Ohashi
June 2019, Biomaterials,
Philipp A Lang, and Karl S Lang, and Haifeng C Xu, and Melanie Grusdat, and Ian A Parish, and Mike Recher, and Alisha R Elford, and Salim Dhanji, and Namir Shaabani, and Charles W Tran, and Dilan Dissanayake, and Ramtin Rahbar, and Magar Ghazarian, and Anne Brüstle, and Jason Fine, and Peter Chen, and Casey T Weaver, and Christoph Klose, and Andreas Diefenbach, and Dieter Häussinger, and James R Carlyle, and Susan M Kaech, and Tak W Mak, and Pamela S Ohashi
January 2016, Frontiers in immunology,
Philipp A Lang, and Karl S Lang, and Haifeng C Xu, and Melanie Grusdat, and Ian A Parish, and Mike Recher, and Alisha R Elford, and Salim Dhanji, and Namir Shaabani, and Charles W Tran, and Dilan Dissanayake, and Ramtin Rahbar, and Magar Ghazarian, and Anne Brüstle, and Jason Fine, and Peter Chen, and Casey T Weaver, and Christoph Klose, and Andreas Diefenbach, and Dieter Häussinger, and James R Carlyle, and Susan M Kaech, and Tak W Mak, and Pamela S Ohashi
December 2002, Microbes and infection,
Philipp A Lang, and Karl S Lang, and Haifeng C Xu, and Melanie Grusdat, and Ian A Parish, and Mike Recher, and Alisha R Elford, and Salim Dhanji, and Namir Shaabani, and Charles W Tran, and Dilan Dissanayake, and Ramtin Rahbar, and Magar Ghazarian, and Anne Brüstle, and Jason Fine, and Peter Chen, and Casey T Weaver, and Christoph Klose, and Andreas Diefenbach, and Dieter Häussinger, and James R Carlyle, and Susan M Kaech, and Tak W Mak, and Pamela S Ohashi
March 2002, The Journal of experimental medicine,
Philipp A Lang, and Karl S Lang, and Haifeng C Xu, and Melanie Grusdat, and Ian A Parish, and Mike Recher, and Alisha R Elford, and Salim Dhanji, and Namir Shaabani, and Charles W Tran, and Dilan Dissanayake, and Ramtin Rahbar, and Magar Ghazarian, and Anne Brüstle, and Jason Fine, and Peter Chen, and Casey T Weaver, and Christoph Klose, and Andreas Diefenbach, and Dieter Häussinger, and James R Carlyle, and Susan M Kaech, and Tak W Mak, and Pamela S Ohashi
June 2010, Nature reviews. Immunology,
Philipp A Lang, and Karl S Lang, and Haifeng C Xu, and Melanie Grusdat, and Ian A Parish, and Mike Recher, and Alisha R Elford, and Salim Dhanji, and Namir Shaabani, and Charles W Tran, and Dilan Dissanayake, and Ramtin Rahbar, and Magar Ghazarian, and Anne Brüstle, and Jason Fine, and Peter Chen, and Casey T Weaver, and Christoph Klose, and Andreas Diefenbach, and Dieter Häussinger, and James R Carlyle, and Susan M Kaech, and Tak W Mak, and Pamela S Ohashi
January 2006, Cytokine,
Philipp A Lang, and Karl S Lang, and Haifeng C Xu, and Melanie Grusdat, and Ian A Parish, and Mike Recher, and Alisha R Elford, and Salim Dhanji, and Namir Shaabani, and Charles W Tran, and Dilan Dissanayake, and Ramtin Rahbar, and Magar Ghazarian, and Anne Brüstle, and Jason Fine, and Peter Chen, and Casey T Weaver, and Christoph Klose, and Andreas Diefenbach, and Dieter Häussinger, and James R Carlyle, and Susan M Kaech, and Tak W Mak, and Pamela S Ohashi
January 2019, Frontiers in immunology,
Philipp A Lang, and Karl S Lang, and Haifeng C Xu, and Melanie Grusdat, and Ian A Parish, and Mike Recher, and Alisha R Elford, and Salim Dhanji, and Namir Shaabani, and Charles W Tran, and Dilan Dissanayake, and Ramtin Rahbar, and Magar Ghazarian, and Anne Brüstle, and Jason Fine, and Peter Chen, and Casey T Weaver, and Christoph Klose, and Andreas Diefenbach, and Dieter Häussinger, and James R Carlyle, and Susan M Kaech, and Tak W Mak, and Pamela S Ohashi
January 2012, PloS one,
Philipp A Lang, and Karl S Lang, and Haifeng C Xu, and Melanie Grusdat, and Ian A Parish, and Mike Recher, and Alisha R Elford, and Salim Dhanji, and Namir Shaabani, and Charles W Tran, and Dilan Dissanayake, and Ramtin Rahbar, and Magar Ghazarian, and Anne Brüstle, and Jason Fine, and Peter Chen, and Casey T Weaver, and Christoph Klose, and Andreas Diefenbach, and Dieter Häussinger, and James R Carlyle, and Susan M Kaech, and Tak W Mak, and Pamela S Ohashi
November 2022, The Journal of experimental medicine,
Copied contents to your clipboard!